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Abstract:  
Background: Gender differences in presentation, management and outcome in patients with 
ST-elevation myocardial infarction (STEMI) are reported. 
Aim: To determine whether female gender is associated with higher in-hospital mortality. 
Methods: Data from ORBI, a regional STEMI registry of 5 years’ standing, were analyzed. 
The main data for presentation, management, in-hospital outcome and prescription at 
discharge were compared between genders. Various adjusted hazard ratios were then 
calculated for in-hospital mortality (women vs. men). 
Results: The analysis included 5,000 patients (mean age = 62.6 ± 13 years), with 1,174 
women (23.5%). Women were a mean 8 years older than men, with more frequent co-
morbidities. Median ischemia time was 215 minutes (26 minutes longer in women, p<0.05). 
Reperfusion strategies in women involved less fibrinolysis, coronary angiography, radial 
access and thrombo-aspiration. Female gender, especially in patients younger than 60 years, 
was associated with poorer in-hospital prognosis (including higher in-hospital mortality: 9% 
vs. 4% in men; p<0.0001), and under-utilisation of the recommended treatment at discharge. 
Moreover, excess female in-hospital mortality was independent of presentation, 
revascularisation time and reperfusion strategy (hazard ratio for women: 1.33, 95% 
confidence interval, 1.01 to 1.76; p=0.04). 
Conclusions: One in 4 patients admitted for STEMI was female, with significant differences 
in presentation. Female gender was associated with less optimal treatment, both in the acute 
phase and at discharge. Effort should be made to reduce those differences, especially as 
female gender was independently associated with elevated risk of in-hospital mortality. 
Abstract word count: 238 
 4 
Résumé: 
Contexte: Des différences liées au sexe sont signalées dans la présentation, la gestion et le 
pronostic des patients hospitalisés pour infarctus du myocarde avec élévation du segment ST 
(IDM ST +). 
Objectif: déterminer si le sexe féminin est associé à une mortalité intra-hospitalière plus 
élevée. 
Méthode: Nous avons analysé les données d’ORBI, un registre régional de 5 ans concernant 
les IDM ST+. Les principales données concernant la présentation, la gestion, le devenir intra-
hospitalier et le traitement à la sortie ont été comparées en fonction du sexe. Ensuite, nous 
avons analysé la mortalité intra hospitalière (femmes vs hommes), avec différentes variables 
d’ajustement. 
Résultats: L'analyse a inclus 5000 patients (âge moyen = 62,6 ± 13 ans), dont 1174 femmes  
(23,5%), qui présentaient des co-morbidités plus fréquentes et étaient 8 ans plus âgées que les 
hommes. Le temps d'ischémie médian était de 215 minutes (26 minutes de plus chez les 
femmes). Comparativement aux hommes, les stratégies de reperfusion chez les femmes 
comportaient moins de fibrinolyse, de coronarographie, d'accès radial et de thrombo-
aspiration. Le sexe féminin, en particulier chez les moins de 60 ans, était associée à un 
mauvais pronostic intra-hospitalier (y compris une plus forte mortalité intra hospitalière: 9% 
contre 4% chez les hommes, p <0,0001), et une sous-utilisation des traitements recommandés 
à la sortie. Par ailleurs, la surmortalité intra hospitalière observée chez les femmes était 
indépendante de la présentation, des délais de revascularisation et des stratégies de 
reperfusion (hasard ratio=1,33, intervalle de confiance 95% :1,01 à 1.76, p = 0,04). 
Conclusions: Une personne sur 4 patients admis pour un IDM ST+ est une femme, avec des 
différences significatives dans la présentation. Le sexe féminin est associé à un traitement 
moins optimal, tant à la phase aiguë qu'à la sortie d’hôpital. Un effort particulier devra être 
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effectué afin de réduire ces différences, d'autant plus que le sexe féminin semble constituer 
dans cette analyse un risque indépendant de surmortalité intra-hospitalière. 
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Introduction: Several studies have reported increased in-hospital mortality in myocardial 
infarction (MI) with persistent ST-segment elevation (STEMI) in women
1-7
. Several 
hypotheses have been put forward to account for this excess female mortality, including more 
serious comorbidity, longer time to revascularization, or less “optimal” reperfusion strategies. 
It is, however, not yet clearly established whether female gender is in itself a risk factor for in-
hospital death in case of STEMI. The present study is an update on gender-linked differences 
in the characteristics, means of treatment, mortality and in-hospital prognosis of patients 
admitted for STEMI. 
 
Method: We used the data from the Brittany Regional Infarction Observatory (Observatoire 
Régional Breton sur l’Infarctus: ORBI)8. Brittany is an administrative Region with a 
population of 3.2 million and 9 interventional cardiology centers (see list in Appendix), for an 
area of 34,023 km². ORBI prospectively includes all patients admitted within 24 hours of 
symptom onset to any of the 9 centers for STEMI (final diagnosis). Demographic and 
electrocardiographic data, treatments, time intervals and in-hospital events are recorded 
prospectively. Overall ischemia time is defined as the time between symptom onset and 
initiation of reperfusion: balloon inflation, in case of primary angioplasty, or administration of 
fibrinolytic treatment. All patients registered by ORBI between July 1
st
, 2006 and August 31
st
, 
2011 were included in the present study. 
Statistical analysis: Qualitative data were expressed as percentages and quantitative data as 
means ± standard deviations, except for times, which were expressed as medians [range]. 
Multiple imputation was performed to take into account missing data
9
 As a first step, 
univariate analysis according to gender, clinical characteristics, time to revascularization, 
revascularization strategy, in-hospital prognosis and discharge prescription was performed. 
Student (or Wilcoxon, as appropriate) and Chi² were used for quantitative and qualitative data 
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respectively. In a second step, in-hospital mortality was analyzed according to gender, using a 
Cox model. The association was presented in the form of a Hazard Ratio (HR) with 95% 
confidence intervals (95% CI). Various models were constructed according to adjustment 
strategy: model 1, non-adjusted; model 2, adjusted for patient characteristics (age, diabetes, 
arterial hypertension, active smoking, anterior STEMI location, 3-vessels or common left 
main coronaropathy); model 3, adjusted for the variables of model 2 and for overall ischemia 
time; and model 4, adjustment for the variables of model 3 and for revascularization 
parameters (coronarography, primary angioplasty, radial arterial approach, thrombo-
aspiration, anti-Gp2b3a administration, fibrinolysis).  
The significance threshold was systematically set at 5%. Statistical analysis used SAS® 
software, version 9.1 (SAS Institute Inc., Cary, NC, USA). 
 
Results: Over the study period, 5,000 patients (mean age, 62.6 ± 13 years) were included in 
ORBI, with 1,174 (23.5%) female. The main patient characteristics and coronaropathy and MI 
data are presented according to gender in Table 1. Emergency myocardial revascularization 
was performed in 4,344 patients (87%): 3,583 (71%) by primary angioplasty and 761 (15%) 
by fibrinolysis. 
The initial emergency call was on the dedicated emergency telephone number 15 (emergency 
medicalized ambulance service: SAMU) for 40% of female versus 44% of male patients 
(p=0.004). ECG when performed before hospital admission showed significant ST-segment 
elevation in 88% of female versus 95% of male patients (p=0.03). The SAMU provided pre-
admission treatment in 55% of female versus 61% of male patients (p<0.001). Finally, direct 
access to the cath lab in case of primary angioplasty was available for 57% of female versus 
66% of male patients (p<0.0001).  
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Median overall ischemia time was 215 minutes [63-1,530 min], and was significantly longer 
for female patients (235 min, vs. 209 min for male patients, p<0.05), with delayed treatment 
at all stages: median pain-to-call time, 60 vs. 44 min (p<0.0001); call-to-door, 130 vs. 125 
min (p<0.05); and door-to-balloon (or thrombo-aspiration) in primary angioplasty, 45 vs. 40 
min (p<0.05). Thus the median time from first medical contact to balloon inflation or 
thrombo-aspiration was 95 min: 100 min in female vs. 94 min in male patients (p<0.05), and 
less than 120 min for respectively 65% and 72% (p<0.0001). Table 2 presents 
revascularization strategies according to gender, showing lower rates of use of the various 
reperfusion techniques in women. 
In-hospital evolution: As seen in Table 3, in-hospital morbidity and mortality were 
significantly higher in women, with higher rates of high-grade atrioventricular block and atrial 
fibrillation and lower left-ventricle ejection fractions. Likewise, total hospital stay was longer. 
Above all, mortality from all causes was higher: 106 (9%) vs. 167 (4%) (p<0.0001). These 
deaths were mainly from cardiovascular causes: 96 (90% of deaths) in female and 149 (89%) 
in male patients. Death from hemorrhage was rare: n=11; 3 male versus 8 female (p<0.001), 
including 8 intracranial hemorrhages (2 male, 6 female; p=0.002) and 1 retroperitoneal 
hematoma (in a male patient). As seen in Table 4, which compares in-hospital mortality by 
age and gender, excess mortality mainly affected female patients under 60 years of age, in 
univariate analysis. Finally, the rate of hemorrhagic events of whatever severity, 
systematically screened in 427 patients, was 3% in female versus 2% in male patients 
(p=0.48). 
Discharge treatment: Table 5 shows the rate of prescription of the various treatments 
recommended by the European Society of Cardiology
10
 at discharge home, according to 
gender, again showing under-prescription for women in all cases. 
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Adjusted analysis of in-hospital mortality: Female STEMI patients showed significantly 
higher non-adjusted in-hospital mortality than males (model 1): HR = 1.96 [1.53-2.52]; 
p<0.0001. This excess mortality persisted after adjustment on patient characteristics (model 
2): HR = 1.36 [1.04-1.79]; p=0.02. It also persisted after adjustment on time to 
revascularization (model 3): HR = 1.37 [1.05-1.80]: p=0.02. Finally, “complete” adjustment, 
on patient characteristics and time to revascularization and revascularization technique (model 
4), gave an HR of 1.33 [95% CI, 1.01-1.76] (p=0.04), revealed excess female in-hospital 
mortality in STEMI, independently of all study parameters (figure 1). 
 
 
Discussion 
The present study highlights the specificities of STEMI and its prognosis in female patients: 
onset associated with higher comorbidity rates, later and less optimal treatment, and above all 
much poorer in-hospital prognosis, especially in younger women. 
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The present female prevalence for STEMI (about 1 in 4) is in full agreement with French 
national data
3, 11
. Likewise, the present rate of comorbidity in female patients is in agreement 
with recent registry reports
2
, notably a higher mean age in females: 65.5 vs. 61.2 years in the 
American registry
7
, 71 vs. 62 years in the German Mitra registry
12
, and 67 vs. 56 years in the 
Korean registry
5
. 
Time to revascularization : ORBI revealed significantly longer ischemia times in women, due 
to less use of the SAMU emergency service, lower ECG input and longer delays to all types 
of treatment, as also found in other registries
13,14
. Thus, the median pain-to-door time in the 
American registry
13
 was 195 min for women, versus 150 min for men, and 217 versus 161 
min in the Korean registry
5
. Most notable was the significantly longer (by 16 min) pain-to-call 
time in the ORBI data, indicating a need for greater awareness of the issue of STEMI on the 
part of women and for early call for specialized help (SAMU) in case of chest pain, to allow 
direct admission to the cath lab
8, 10
. 
Management: The present study also found a very clear gender-related difference in coronary 
revascularization strategy. Here again, under-implementation of fibrinolysis and angioplasty 
in female patients has frequently been reported
5, 6, 12, 13, 15
. Most registries, however, fail to 
specify revascularization techniques, and data on arterial approach or thrombo-aspiration, for 
example, are seldom reported. The present study found significant differences in these two 
aspects of revascularization, yet recommended (European Society of Cardiology’s guideline: 
IIa
10
): although of proven benefit in terms of mortality
16
, the radial approach is less often used 
in female patients: 40% vs. 51%; p<0.0001. Likewise, despite proof of benefit
17
, thrombo-
aspiration is again less often used in women (46% vs. 55%; p<0.0001).  
Prognosis: Poorer in-hospital prognosis for female STEMI patients has been frequently 
reported
1, 5-7, 18, 19
. The main contribution of the present study lies in its analysis of this excess 
female mortality, with a 2-fold greater rate of in-hospital death in women.  
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Firstly, it emerged that the excess mortality exclusively concerned younger women, being 
significant only in those under 60 years of age, with a trend in 60-to-70 year-olds; in older 
female patients, no differential mortality was found. This age-gender interaction was also 
observed in the American registry
7
, with post-STEMI in-hospital mortality 98% greater in 50 
year-old women than in men of the same age, but identical in both sexes after 80 years: 12.2% 
in female and 12.3% in male patients. This is an especially worrying factor as a recent 
analysis of French STEMI data found a constant increase in the proportion of young women 
in the STEMI population over the last 15 years: 11.8% of women were aged less than 60 
years in 1995, versus 25.5% in 2010 (p<0.001)
3
. 
Moreover, it emerged that this excess mortality was not simply due to greater comorbidity 
(model 2), longer time to revascularization (model 3) or revascularization strategies that were 
less “aggressive” and less in line with scientific recommendations (model 4). Rather, female 
gender as such emerged as a factor of elevated risk of in-hospital mortality. Few registries 
have undertaken such analysis of the female in-hospital mortality they display. However, an 
analysis of the Korean data, using a methodology similar to the present study, showed that the 
excess female mortality that persisted after adjustment on age became non-significant when 
adjusted on age, medical history, hemodynamic status and “clinical performance”5. A 
previous analysis of data from the State of New York registry also showed significant excess 
mortality in under-75 year-old women that disappeared after adjustment on age, comorbidity 
and hemodynamic status
20
. Likewise, a recent report from a French registry also highlighted 
an impact of the age-gender interaction, but with higher hospital mortality in the subgroup of 
over-65 year old women
21
. This monocentric registry studied 2600 patients (including 199 
under-65 year-old women) in a 23 years period. Therefore, the impact of this age-gender 
interaction is different according to the inclusion period. One quality of our multicentric 
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registry is the inclusion of a high number of patients, in a quite short period, with 
homogenous STEMI-support. 
We have no clear explanation for this excess female mortality. It has been suggested that, in 
STEMI, pre-hospital mortality is higher in male subjects
22
, counterbalancing the excess 
female in-hospital mortality. It is also established that young women enjoy hormonal 
protection against atherosclerosis
23
; it may thus be the case that pre-menopausal women 
admitted for STEMI are those with especially severe atherosclerosis or in whom risk factors 
are accumulated. Moreover, as young women show less stenosis in the coronary network than 
men, they develop a lower ischemic myocardial protection response, entailing greater 
vulnerability to acute ischemia
24
. And finally, the mechanism of coronary occlusion may vary 
according to age, with plaque erosion predominating in younger subjects and rupture in the 
over-50 year-olds
25
. 
Study limitations: As ORBI is a specifically French registry, the present findings may not be 
extrapolated elsewhere. Moreover, ORBI is by definition restricted to patients admitted to an 
interventional cardiology center, and this may induce selection bias: STEMI cases managed 
medically in a non-interventional setting are not included. It is, however, unlikely that women 
are referred differently from male patients of the same age group. 
Conclusion 
The present analysis of ORBI registry data found that about a quarter of patients admitted for 
STEMI were female, with a significantly greater rate of comorbidity than in men. Moreover, 
time to revascularization was significantly longer, partly due to women delaying their call for 
medical help, and treatment strategies were less optimal, both in the acute phase and at 
discharge. Women, and especially younger women, thus show excess in-hospital mortality 
that is only partly accounted for by the above factors and persists after adjustment. 
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It would therefore seem necessary to raise awareness of the issue: in the female population in 
particular, but also in emergency staff and cardiologists. Only management that is at least as 
“optimal” for women as for men can bring down this mortality rate. 
 
Acknowledgments:  
- Thanks to the team of Clinical Research Assistants who ensured data collection: E. Babin 
and A. Piel (CHU de Rennes), P. Héry (Clinique St Laurent, Rennes), F. Langlais (CH de St 
Brieuc), P. Dias and C. Kergoulay (CHU de Brest), and P. Rameau and M. Paquin (CH de 
Quimper); 
- and to all the cardiologists and emergency and SAMU staff who collated the data. 
 
APPENDIX 
The following medical centres participated in this study 
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Quimper; Clinique du Grand Large, Brest. 
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 Table 1: Main patient characteristics according to gender. 
 
 
Male 
(n=3,826) 
Female 
(n=1,174) 
p 
Age 60.8 ±12 68.8 ±14 <0.001 
Arterial hypertension  1,377 (36%) 634 (54%) <0.001 
Dyslipidemia 1,989 (52%) 528 (45%) <0.001 
Diabetes 420 (11%) 152 (13%) 0.06 
Active smoking 1,568 (41%) 305 (26%) <0.001 
Body-mass index (kg/m²) 26.8 ±3 25.5 ±5 <0.001 
Known coronaropathy 734 (19%) 208 (18%) 0.2 
History of myocardial infarction 306 (8%) 47 (4%) <0.001 
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Anterior STEMI location 1,606 (42%) 537 (45%) 0.02 
3-vessels or common left main 
coronaropathy 
700 (18%) 183 (15%) 0.03 
Killip III or IV at admission 182 (5%) 92 (8%) <0.001 
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Table 2: Univariate analysis of coronary revascularization techniques according to 
patient gender 
 
 
Male 
(n=3,826) 
Female 
(n=1,174) 
p 
 
Primary 
strategy 
 
 
Fibrinolysis 618 (16%) 143 (12%) 0.0009 
Primary angioplasty 2,754 (72%) 829 (70%) 0.36 
No acute-phase reperfusion: 454 (12%) 203 (18%) <0.0001 
 
- no acute-phase coronarography  
- acute-phase coronarography 
without angioplasty 
- acute-phase coronarography with 
delayed angioplasty 
 
 
229 (6%) 
 
178 (5%) 
 
47 (1%) 
 
 
107 (9%) 
 
90 (8%) 
 
5 (<1%) 
 
 
Anti-Gp2b3a 2,269 (59%) 628 (53%) 0.0004 
Coronarography (at admission or otherwise) 3,772 (98%) 1,122 (95%) <0.0001 
Radial approach* 1,348 (51%) 303 (40%) <0.0001 
Thrombo-aspiration
**
 1,433 (55%) 388 (46%) <0.0001 
Stent
**
 2,188 (85%) 649 (78%) 0.4 
Drug Eluting Stent
**
 319 (12%) 99 (12%) 0.8 
TIMI 3 flow (spontaneous, after fibrinolysis or at 
end of angioplasty)
†
 
2,555 (91%) 758 (82%) 0.02 
 
*percentage of coronarography patients with data available (n=2,618 male, 743 female). 
** percentage of primary angioplasty patients. 
† 
percentage of acute-phase coronarography patients (n=2,799 male, 924 female). 
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Table 3: In-hospital outcome according to gender 
 
 
 
Male 
(n=3,826) 
Female 
(n=1,174) 
p 
Atrial fibrillation  138 (3%) 82 (7%)  <0.0001 
High-grade atrioventricular block 112 (3%) 68 (6%) <0.0001 
Total hospital stay (days) 6.7 ±4 7.6 ±4 <0.0001 
Left ventricle ejection fraction (%, on 
echocardiography) 
50.5 ±10 49.4 ±11 0.004 
Mortality 167 (4%) 106 (9%) <0.0001 
Mortality from cardiovascular causes,  
Including: 
149 (4%) 96 (8%) <0.0001 
 
- cardiogenic shock 
 
60 
 
41 
 
 
- mechanical complication  30 26  
- arrhythmia/conduction disorder 30 18  
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Table 4: Mortality according to age group and gender. 
 
 
Deaths Men Women Total  p-value 
Age <  60 yrs 34/1,844 (1.8%) 13/317 (4.1%) 47/2,161 (2.1%) 0.01 
60 ≤ age < 70 32/930 (3.4%) 12/202 (5.9%) 44/1,132 (3.9%) 0.09 
70 ≤ age < 80 54/743 (7.2%) 23/332 (6.9%) 77/1,075 (7.1%) 0.84 
80 ≤ age 47/308 (15.2%) 58/323 (17.9%) 105/631 (16.6%) 0.36 
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Table 5: Discharge prescription according to gender, for patients discharged alive from 
the hospital 
 
 
 
 
Male 
(n=3,659) 
Female 
(n=1,068) 
p 
Aspirin 3,584 (98%) 1,022 (95%) <0.0001 
Clopidogrel/Prasugrel 3,506 (96%) 993 (93%) <0.0001 
Beta-blockers 3,349 (91%) 940 (88%) 0.001 
Angiotensin conversion enzyme 
inhibitor/Sartan 
2,481 (67%) 662 (62%) <0.0001 
Statin 3,475 (95%) 955 (89%) <0.0001 
Cardiovascular rehabilitation 1,577 (43%) 267 (25%) <0.0001 
 
